BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7889468)

  • 1. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
    Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
    Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Folia Histochem Cytobiol; 2009 Jan; 47(3):447-51. PubMed ID: 20164030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors in progression of human esophageal and gastric carcinomas.
    Yoshida K; Yasui W; Ito H; Tahara E
    Exp Pathol; 1990; 40(4):291-300. PubMed ID: 2098274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
    Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
    Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
    Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
    Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of epidermal growth factor with invasion and metastasis in human gastric cancer.
    Onda M; Tokunaga A; Nishi K; Yoshiyuki T; Shimizu Y; Kiyama T; Mizutani T; Matsukura N; Tanaka N; Yamashita K
    Jpn J Surg; 1990 May; 20(3):269-74. PubMed ID: 2193178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
    Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
    Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
    Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
    World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma.
    Aoyagi K; Kohfuji K; Yano S; Murakami N; Miyagi M; Takeda J; Shirouzu K
    Kurume Med J; 2001; 48(3):197-200. PubMed ID: 11680933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
    Yamanaka Y
    Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
    Yonemura Y; Ninomiya I; Yamaguchi A; Fushida S; Kimura H; Ohoyama S; Miyazaki I; Endou Y; Tanaka M; Sasaki T
    Cancer Res; 1991 Feb; 51(3):1034-8. PubMed ID: 1670998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of EGF, c-erbB-2 and EGFR in intestinal variant of gastric adenocarcinomas.
    Docea AO; Mitruţ P; Cernea D; Georgescu CC; Olimid D; Mărgăritescu C; Dumitrescu D
    Rom J Morphol Embryol; 2013; 54(3):545-54. PubMed ID: 24068402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2.
    Suzuki T; Tsuda T; Haruma K; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(5):385-91. PubMed ID: 7637956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer.
    Takita M; Onda M; Tokunaga A
    Nihon Ika Daigaku Zasshi; 1998 Oct; 65(5):358-66. PubMed ID: 9808988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.
    Gullick WJ; Srinivasan R
    Breast Cancer Res Treat; 1998; 52(1-3):43-53. PubMed ID: 10066071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.
    Ravery V; Grignon D; Angulo J; Pontes E; Montie J; Crissman J; Chopin D
    Urol Res; 1997; 25(1):9-17. PubMed ID: 9079740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.